Microlin Bio is an emerging therapeutics company focusing on microRNA and their role in oncology.

Recent Microlin Bio News:

January 14, 2016
Microlin Bio, Inc. Announces Ticker Symbol Change to MICB

January 12, 2016
Microlin Bio, Inc. Announces Publication of Results From AntimiR-21 Lung Cancer Study in Molecular Pharmaceutics